• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-13

  Oliveira et al. show that naturally occurring angiotensin fragments can alter SARS-CoV-2 spike-protein binding to host receptors, with particularly strong effects on AXL. The structure–activity analysis identifies peptide length, N-terminal deletion, and tyrosine modification as important variables, providing a mechanistic starting point for studying links between renin–angiotensin signaling and viral-entry biology.

• FCCP Workflows for Mitochondrial and HIF Research

  2026-08-12

  FCCP connects mitochondrial proton-gradient disruption with measurable changes in oxygen consumption, ATP production, and HIF-associated signaling. This guide separates acute bioenergetic assays from longer cancer-cell treatments and shows how the compound can complement emerging tumor-associated macrophage immunometabolism research.

• Beyond Viability: Measuring Cancer Drug Responses

  2026-08-12

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that anti-cancer drugs can combine proliferative arrest and cell killing in different proportions and on different timescales. This dual-metric framework offers a more precise way to design and interpret in vitro drug-response experiments, while clarifying what viability measurements can and cannot predict in translational models.

• Angiotensin III: Mechanism-First Research Guide

  2026-08-11

  Explore how Angiotensin III and its Arg-Val-Tyr-Ile-His-Pro-Phe sequence shape RAAS signaling, endocrine responses, and receptor-aware assay design. This guide connects established cardiovascular biology with a recent binding-assay innovation while clearly separating validated evidence from emerging hypotheses.

• TMRE and the New Logic of Mitochondrial Failure

  2026-08-11

  Mitochondrial membrane potential is more than a viability signal: it is a mechanistic waypoint connecting ion imbalance, energy failure, and cell fate. This article explains how the TMRE mitochondrial membrane potential assay kit can help translational researchers validate sodium-driven mitochondrial dysfunction while avoiding the interpretive limits of a single fluorescent endpoint.

• Lenalidomide in Myeloma Research Workflows

  2026-08-10

  Lenalidomide (CC-5013) supports integrated myeloma experiments that connect direct tumor-cell effects with immune restoration, interferon signaling, and angiogenesis control. This guide translates recent DOT1L findings into practical combination assays, dosing workflows, and troubleshooting decisions.

• Reversine and the Logic of Aurora Kinase Control

  2026-08-09

  Reversine offers translational researchers a mechanistic lens for studying Aurora kinase signaling, mitotic checkpoint control, cancer cell proliferation inhibition, and apoptosis induction in cancer cells. This article connects checkpoint biology to practical assay design and a disciplined strategy for cancer research.

• Calpeptin: Calpain Inhibitor for Fibrosis Research

  2026-08-08

  Calpeptin is a nanomolar calpain inhibitor used to investigate calcium-dependent cysteine protease signaling. Product data report activity against human calpain 1 and reductions in fibrotic and inflammatory markers in fibroblast and mouse pulmonary fibrosis models.

• Mechanisms of Cell Death in Heart Disease

  2026-08-07

  This review reframes cardiac injury by showing that apoptosis and necrosis are distinct but interconnected outcomes of regulated signaling, rather than wholly separate or passive processes. Its pathway-based analysis offers practical guidance for interpreting cell-death phenotypes and for evaluating pharmacological interventions, while also defining limits on translating cardiovascular mechanisms to other disease models.

• LRRC8A-Caveolin-1 Axis Drives PDAC Growth via Cholesterol Re

  2026-08-07

  This study uncovers how a cholesterol-dependent LRRC8A-caveolin-1 complex sustains KRAS/EGFR signaling, ribosome biogenesis, and cell growth in pancreatic ductal adenocarcinoma. Elucidation of this axis highlights new mechanistic links between membrane dynamics and oncogenic progression, offering a potential therapeutic target in aggressive pancreatic cancer.

• FLAG tag Peptide: Strategic Leverage for Exosome Pathway Res

  2026-08-06

  This thought-leadership article explores the mechanistic and strategic value of the FLAG tag Peptide (DYKDDDDK) in advancing recombinant protein research, with a focus on translational applications in exosome biology. By integrating recent mechanistic insights into ESCRT-independent exosome pathways and best-in-class purification protocols, it provides actionable guidance for researchers seeking reproducibility and scalability in complex biological systems.

• BFH772 (VEGFR2 inhibitor): Protocols, QC, and Workflow Guida

  2026-08-06

  BFH772 is a potent, selective VEGFR2 inhibitor designed for researchers requiring precise inhibition of VEGFR2-driven angiogenesis, especially in tumor model studies. It is optimal for workflows emphasizing kinase selectivity and organic solvent compatibility, but is not suitable for protocols requiring water solubility or long-term solution storage.

• LY2109761: Dual TGF-β Kinase Inhibition in Fibrosis and Onco

  2026-08-05

  Explore how LY2109761, a potent TGF-β receptor type I and II dual inhibitor, advances fibrosis and cancer research through Smad2/3 phosphorylation blockade and unique preclinical outcomes. This article delivers new practical and mechanistic insights for experimental design.

• Docetaxel Workflows: Precision in Cancer Chemotherapy Resear

  2026-08-05

  Docetaxel (Taxotere) stands apart as a microtubule stabilization agent, enabling robust, reproducible cancer chemotherapy research. This guide delivers stepwise workflows, critical troubleshooting, and experimental insights for maximizing assay impact and decoding resistance mechanisms.

• Calpeptin as a Calpain Inhibitor: Innovations in Fibrosis an

  2026-08-04

  Discover how Calpeptin, a potent calpain inhibitor, uniquely advances fibrosis and extracellular vesicle (EV) research. This article provides a deep scientific analysis, practical assay guidance, and new perspectives distinct from prior work.

15460 records 1/1031 page Next 12345 下5页 Last page